12/09/2024 2:18 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024 3:51 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2024 3:55 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 2:23 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024 3:26 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2024 3:15 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2024 3:19 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
11/29/2024 2:49 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024 2:54 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024 2:35 PM | Mock James M (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024 5:33 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/08/2024 3:19 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 7:49 AM | Hussain Abbas (Reporting) Moderna (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/04/2024 7:52 AM | Hussain Abbas (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2024 6:03 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2024 5:03 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/10/2024 3:15 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2024 2:29 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024 4:42 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/04/2024 3:26 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 2:42 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 3:34 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 3:37 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 3:45 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2024 3:30 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024 3:33 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 3:02 PM | Moderna (Issuer) Rubenstein David M. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 5:31 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 3:19 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024 6:05 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:23 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 10:44 AM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 3:19 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 3:34 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2024 2:28 PM | Mock James M (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 3:19 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Genesis leading the smart algo revolution? (Ad) I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before…
Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from.
Here’s why:
It does all the heavy lifting for you… automatically.
Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart! You’ll want to see what I’ve put on this page right here |
06/21/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:28 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 11:45 AM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2024 3:20 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 6:01 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 4:41 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 4:26 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024 2:16 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 3:22 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024 4:27 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 4:20 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 2:36 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 2:20 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 2:11 PM | Mock James M (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 3:36 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 3:34 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 3:12 PM | Klinger Shannon Thyme (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 2:12 PM | Mock James M (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 2:14 PM | Garay Arpa (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 2:20 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 2:22 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 2:21 PM | Mock James M (Reporting) Mock James M (Reporting) Moderna (Subject) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024 2:21 PM | Klinger Shannon Thyme (Reporting) Moderna (Subject) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 3:27 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 3:23 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 12:41 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024 3:03 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 3:43 PM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024 3:24 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024 3:51 PM | LANGER ROBERT (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:54 PM | Horning Sandra (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:57 PM | Moderna (Issuer) Tallett Elizabeth E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:59 PM | Moderna (Issuer) SAGAN PAUL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 4:02 PM | Moderna (Issuer) Nader Francois (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 3:42 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 5:31 AM | Moderna (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 3:21 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:17 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024 3:23 PM | Hoge Stephen (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 9:58 AM | Hoge Stephen (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad) Elon Musk believes his new AI product will be worth an incredible $9 trillion.
But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. |
04/10/2024 3:22 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 1:03 PM | Moderna (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/09/2024 3:09 PM | Mock James M (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 2:32 PM | Mock James M (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 3:20 PM | AFEYAN NOUBAR (Reporting) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 3:22 PM | AFEYAN NOUBAR (Reporting) AFEYAN NOUBAR (Reporting) Moderna (Subject) Moderna (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024 6:00 PM | AFEYAN NOUBAR (Reporting) Moderna (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |